Estrogen receptor 1 gene expression and its combination with estrogen receptor 2 or aromatase expression predicts survival in non-small cell lung cancer

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Aresti, Unai ^a   Carrera, Sergio ^b   Iruarrizaga, Eluska ^b   Fuente, Natalia ^b   Marrodan, Ines ^b   De Lobera, Abigail Ruiz ^b   Muñoz, Alberto ^b   Buque, Aitziber ^a   Condori, Elizabeth ^b   Ugalde, Irene ^b   Calvo, Begoña ^a   Vivanco, Guillermo López ^b  

^a Oncology Research Laboratory   (Spain)

^b HOSPITAL DE CRUCES   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; CYP19A1 PROTEIN, HUMAN; ESR2 PROTEIN, HUMAN; ESTROGEN RECEPTOR ALPHA, HUMAN;

ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CONTROLLED STUDY; CYP19A1 GENE; DISEASE ASSOCIATION; ERS1 GENE; ERS2 GENE; FEMALE; GENE EXPRESSION; GENE FUNCTION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NON SMALL CELL LUNG CANCER; OVERALL SURVIVAL; PREDICTION; PROTEIN CONTENT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE LEVEL; GENETICS; LUNG TUMOR; MORTALITY; SURVIVAL RATE;

AROMATASE; CARCINOMA, NON-SMALL-CELL LUNG; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; GENE EXPRESSION; HUMANS; LUNG NEOPLASMS; MALE; SURVIVAL RATE;

EID: 84907930842     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0109659     Document Type: Article

References (35)

1. American Cancer Society (2014) Cancer Facts and Figures 2014. Atlanta: American Cancer Society.
2. Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62: 10-29.
3. Chen GG, Zeng Q, Tse GM (2008) Estrogen and its receptors in cancer. Med Res Rev 28: 954-974.
4. Stabile LP, Siegfried JM (2004) Estrogen receptor pathways in lung cancer. Curr Oncol Rep 6: 259-267.
5. Taioli E, Wynder EL (1994) Re: Endocrine factors and adenocarcinoma of the lung in women. J Natl Cancer Inst 86: 869-870.
6. Hershberger PA, Vasquez AC, Kanterewicz B, Land S, Siegfried JM, et al. (2005) Regulation of endogenous gene expression in human non-small cell lung cancer cells by estrogen receptor ligands. Cancer Res 65: 1598-1605.
7. Foster PA (2008) Steroid metabolism in breast cancer. Minerva Endocrinol 33: 27-37.
8. Márquez-Garbán DC, Chen HW, Fishbein MC, Goodglick L, Pietras RJ (2007) Estrogen receptor signaling pathways in human non-small cell lung cancer. Steroids 72: 135-143.
9. Stabile LP, Davis AL, Gubish CT, Hopkins TM, Luketich JD, et al. (2002) Human non-small cell lung tumors and cells derived from normal lung express both estrogen receptor alpha and beta and show biological responses to estrogen. Cancer Res 62: 2141-2150.
10. Pearce ST, Jordan VC (2004) The biological role of estrogen receptors alpha and beta in cancer. Crit Rev Oncol Hematol 50: 3-22.
11. Pietras RJ, Márquez DC, Chen HW, Tsai E, Weinberg O, et al. (2005) Estrogen and growth factor receptor interactions in human breast and non-small cell lung cancer cells. Steroids 70: 372-381.
12. Kawai H, Ishii A, Washiya K, Konno T, Kon H, et al. (2005) Combined overexpression of EGFR and estrogen receptor alpha correlates with a poor outcome in lung cancer. Anticancer Res 25: 4693-4698.
13. Yager JD, Davidson NE (2006) Estrogen carcinogenesis in breast cancer. N Engl J Med 354: 270-282.
14. Arai N, Ström A, Rafter JJ, Gustafsson JA (2000) Estrogen receptor beta mRNA in colon cancer cells: growth effects of estrogen and genistein. Biochem Biophys Res Commun 270: 425-431.
15. Campbell-Thompson M, Lynch IJ, Bhardwaj B (2001) Expression of estrogen receptor (ER) subtypes and ERbeta isoforms in colon cancer. Cancer Res 61: 632-640.
16. Zeng Q, Chen GG, Vlantis AC, van Hasselt CA (2007) Oestrogen mediates the growth of human thyroid carcinoma cells via an oestrogen receptor-ERK pathway. Cell Prolif 40: 921-935.
17. Márquez-Garbán DC, Chen HW, Goodglick L, Fishbein MC, Pietras RJ (2009) Targeting aromatase and estrogen signaling in human non-small cell lung cancer. Ann N Y Acad Sci 1155: 194-205.
18. Mah V, Seligson DB, Li A, Márquez DC, Wistuba II, et al. (2007) Aromatase expression predicts survival in women with early-stage non small cell lung cancer. Cancer Res 67: 10484-10490.
19. Rades D, Setter C, Dahl O, Schild SE, Noack F (2012) The prognostic impact of tumor cell expression of estrogen receptor-a, progesterone receptor, and androgen receptor in patients irradiated for nonsmall cell lung cancer. Cancer 118: 157-163.
20. Atmaca A, Al-Batran S-E, Wirtz RM, Werner D, Zirlik S, et al. (2014) The validation of estrogen receptor 1 mRNA expression as a predictor of outcome in patients with metastatic non-small cell lung cancer. Int J Cancer 134: 2314- 2321.
21. Brueckl WM, Al-Batran S-E, Ficker JH, Claas S, Atmaca A, et al. (2013) Prognostic and predictive value of estrogen receptor 1 expression in completely resected non-small cell lung cancer. Int J Cancer 134: 1825-1831.
22. Mah V, Marquez D, Alavi M, Maresh EL, Zhang L, et al. (2011) Expression levels of estrogen receptor beta in conjunction with aromatase predict survival in non-small cell lung cancer. Lung Cancer 74: 318-325.
23. Fasco MJ, Hurteau GJ, Spivack SD (2002) Gender-dependent expression of alpha and beta estrogen receptors in human nontumor and tumor lung tissue. Mol Cell Endocrinol 188: 125-140.
24. Mollerup S, Jørgensen K, Berge G, Haugen A (2002) Expression of estrogen receptors alpha and beta in human lung tissue and cell lines. Lung Cancer 37: 153-159.
25. Oyama T, Kagawa N, Sugio K, Uramoto H, Hatano O, et al. (2009) Expression of aromatase CYP19 and its relationship with parameters in NSCLC. Front Biosci 14: 2285-2292.
26. Gomez-Fernandez C, Mejias A, Walker G, Nadji M (2010) Immunohistochemical expression of estrogen receptor in adenocarcinomas of the lung: The antibody factor. Appl Immunohistochem Mol Morphol 18: 137-141.
27. Raso MG, Behrens C, Herynk MH, Liu S, Prudkin L, et al. (2009) Immunohistochemical expression of estrogen and progesterone receptors identifies a subset of NSCLCs and correlates with EGFR mutation. Clin Cancer Res 15: 5359-5368.
28. Miki Y, Abe K, Suzuki S, Suzuki T, Sasano H (2011) Suppression of estrogen actions in human lung cancer. Mol Cell Endocrinol 340: 168-174.
29. Olivo-Marston SE, Mechanic LE, Mollerup S, Bowman ED, Remaley AT, et al. (2010) Serum estrogen and tumor-positive estrogen receptor-alpha are strong prognostic classifiers of non-small-cell lung cancer survival in both men and women. Carcinogenesis 31: 1778-1786.
30. Wu CT, Chang YL, Shih JY, Lee YC (2005) The significance of estrogen receptor beta in 301 surgically treated non-small cell lung cancers. J Thorac Cardiovasc Surg 130: 979-986.
31. Kawai H, Ishii A, Washiya K, Konno T, Kon H, et al. (2005) Estrogen receptor alpha and beta are prognostic factors in non-small cell lung cancer. Clin Cancer Res 11: 5084-5089.
32. Stabile LP, Dacic S, Land SR, Lenzner DE, Dhir R, et al. (2011) Combined analysis of estrogen receptor beta-1 and progesterone receptor expression identifies lung cancer patients with poor outcome. Clin Cancer Res 17: 154-164.
33. Skov BG, Fischer BM, Pappot H (2008) Oestrogen receptor beta over expression in males with non-small cell lung cancer is associated with better survival. Lung Cancer 59: 88-94.
34. Abe K, Miki Y, Ono K, Mori M, Kakinuma H, et al. (2010) Highly concordant coexpression of aromatase and estrogen receptor beta in non-small cell lung cancer. Hum Pathol 41: 190-198.
35. Verma MK, Miki Y, Abe K, Nagasaki S, Niikawa H, et al. (2012) Co-expression of estrogen receptor beta and aromatase in Japanese lung cancer patients: gender-dependent clinical outcome. Life Sci 91: 800-808.